ReviewClinics in chest medicine2017
Evaluation and Management of the Potential Lung Donor.
Review in Clinics in chest medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 33 citations in OpenAlex.
- Strategies for Maximising Lung Utilisation in Donors After Brain and Cardiac Death: A Narrative Review.Journal of clinical medicine · 2025Review
- Temperature Dynamics of Porcine and Human Lungs During Static Ice Storage: Ice Is Not 4 °C.Journal of clinical medicine · 2025Article
- The Impact of Donor Smoking on Primary Graft Dysfunction and Mortality after Lung Transplantation.American journal of respiratory and critical care medicine · 2024Article
- Current trends in candidate selection, contraindications, and indications for lung transplantation.Journal of thoracic disease · 2021Review
- Procurement of lungs from brain-dead donors.Indian journal of thoracic and cardiovascular surgery · 2021Review
- The Low Utilization Rate of Donor Lungs in China: A Single-Center Experience.Annals of transplantation · 2021Article
- Lung Transplantation, Pulmonary Endothelial Inflammation, and Ex-Situ Lung Perfusion: A Review.Cells · 2021Review
- Ischemia-reperfusion Injury in the Transplanted Lung: A Literature Review.Transplantation direct · 2021Review
- Residual endotoxin induces primary graft dysfunction through ischemia/reperfusion-primed alveolar macrophages.The Journal of clinical investigation · 2020Article
- Early Graft Dysfunction after Lung Transplantation.Current pulmonology reports · 2018Article
- Donor lung management: Changing perspectives.Lung India : official organ of Indian Chest SocietyReview
- Anesthesia for lung transplantation: A narrative review.Journal of anaesthesiology, clinical pharmacologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
The expansion of the donor lung pool has involved an evidence-driven redefinition of acceptable donors. Proceeding with transplantation with an acceptable rather than ideal donor depends on specific patient-related and organ-related risk factors as well as the severity of recipient illness. Although the physiologic optimization of brain-dead donors has not changed significantly in recent years, the use of donor management protocols has improved procurement rates. Ex vivo lung perfusion is an increasingly viable strategy to recondition lungs that would otherwise fall below the acceptable threshold for transplant. Ex vivo perfusion trials for preservation of standard donor lungs are ongoing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.